Portal Vein ThrombosisCirrhosisPortal Hypertension Related to CirrhosisPortal Hypertension, Noncirrhotic
Study summary
This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
* all patients were diagnosed as PVT by CTA at admission.
Exclusion Criteria:
* patients with hepatocellular carcinoma;
* patients with extrahepatic malignancies;
* history of liver transplantation or TIPS;
* lack of information regarding anticoagulation therapy；
* those with cavernous transformation of the portal vein(CTPV) .
Primary outcome measure(s)
PVT recanalization at 1 year — From the first abdominal imaging assessment after admission, until the occurrence of PVT recanalization at 1 year, death, or the last follow-up, whichever came first
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.